Emerging technologies for metabolite generation and structural diversification
Kevin P. Cusack, Hannes F. Koolman, Udo E. W. Lange et al. · Bioorganic & Medicinal Chemistry Letters · 2013
Multiple technologies have emerged for structural diversification and efficient production of metabolites of drug molecules. These include expanded use of enzymatic and bioorganic transformations that mimic biological systems, biomimetic catalysis and electrochemical techniques. As this field continues to mature the breadth of transformations is growing beyond simple oxidative processes due in part to parallel development of more efficient catalytic methods for functionalization of unactivated scaffolds. These technologies allow for efficient structural diversification of both aromatic and aliphatic substrates in many cases via single step reactions without the use of protecting groups.
Cited by 68 works. doi:10.1016/j.bmcl.2013.08.003 Open-access PDF
Authors
References
- The influence of drug-like concepts on decision-making in medicinal chemistry
- Towards mild metal-catalyzed C–H bond activation
- Catalysis for fluorination and trifluoromethylation
- Direct C−H Transformation via Iron Catalysis
- A Predictably Selective Aliphatic C–H Oxidation Reaction for Complex Molecule Synthesis
- Structure and Chemistry of Cytochrome P450
- Beyond Directing Groups: Transition‐Metal‐Catalyzed CH Activation of Simple Arenes
- Controlling Site Selectivity in Palladium-Catalyzed C–H Bond Functionalization
- Combined Effects on Selectivity in Fe-Catalyzed Methylene Oxidation
- Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes